CSL Behring

CSL Behring is a global biotechnology company with a focus on developing and manufacturing innovative biopharmaceuticals for the treatment of rare and serious diseases. The company specializes in the production of plasma-derived and recombinant therapies, particularly in the areas of immunology, neurology, and hematology. Founded in 1916, CSL Behring has a long history of expertise in the field of blood plasma fractionation and has developed a range of therapies for conditions such as hemophilia, primary immune deficiencies, and autoimmune diseases.